Patent · US Active

Ocular implant with shape change capabilities

US10016301B2 · kind B2 · utility

5Cited by

129References

7Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Thomas A. Silvestrini · Alamo, US
Steven John · Menlo Park, US
Jose L. Garcia · Menlo Park, US
Richard S. Lilly · San Jose, US

Key dates

Filing date	Dec 24, 2013
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Mar 3, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M37/00
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

Disclosed are devices, methods and systems for treatment of eye disease such as glaucoma. Implants are described herein that enhance aqueous flow through the normal outflow system of the eye with minimal to no complications. The implant can be reversibly deformed to a first shape, such as a generally linear shape conducive to insertion. Upon insertion, the implant can deform to a second shape, such as a generally non-linear shape conducive to retention within the eye. The shape also improves fluid flow from the anterior chamber and prevents or reduces clogging.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.